Modern Diagnost.

Why is Modern Diagnostic & Research Centre Ltd falling/rising?

As of 09-Jul, the stock price of Modern Diagnostic & Research Centre Ltd is Rs 52.00, unchanged from the previous session and underperforming by 1.17% compared to its sector. The stock has declined 10.34% over the past month and is close to its 52-week low, indicating a bearish trend despite increased investor participation.

As of 09-Jul, the stock price of Modern Diagnostic & Research Centre Ltd is currently at Rs 52.00, showing no change from the previous trading session. The stock has underperformed today, with a performance that is 1.17% lower than its sector. Additionally, it is 4.81% away from its 52-week low of Rs 49.5, indicating that it is close to a significant low point.<BR><BR>In terms of recent performance, the stock has declined by 10.34% over the past month, while the benchmark Sensex has increased by 3.82% during the same period. This stark contrast suggests that the stock is not keeping pace with broader market trends. Furthermore, the stock is currently higher than its 5-day moving average but lower than its 20-day, 50-day, 100-day, and 200-day moving averages, which could indicate a bearish trend in the longer term.<BR><BR>Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 56.25% against the 5-day average. However, the overall liquidity remains modest, as the stock is liquid enough for trades of Rs 0 crore based on 2% of the 5-day average traded value.<BR><BR>In summary, the combination of underperformance compared to the sector, significant declines over the past month, and proximity to a 52-week low contribute to the current stagnation in the stock price of Modern Diagnostic & Research Centre Ltd.

Which are the latest news on Modern Diagnost.?

What does Modern Diagnost. do?

Modern Diagnostic & Research Centre Ltd provides diagnostic services in the healthcare sector, operating since 1985 and incorporated in 2012. It has a market cap of INR 88 Cr, with key metrics including a P/E of 16.00 and a debt-equity ratio of 0.47.

Overview: <BR>Modern Diagnostic & Research Centre Ltd operates in the healthcare services industry, providing diagnostic services.<BR><BR>History: <BR>The company was incorporated as "Modern Diagnostic & Research Centre Private Limited" on April 16, 2012, after starting operations in 1985 under the name 'Modern X-Ray and Clinical Lab'. There are no recent sales and profit reports available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 88 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 16.00 <BR>Industry P/E: 60 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.47 <BR>Return on Equity: 8.97% <BR>Price-to-Book: 1.50 <BR><BR>Contact Details: <BR>Address: Not available <BR>Phone: Not available <BR>Email: Not available <BR>Website: Not available

How big is Modern Diagnost.?

As of 10th June, Modern Diagnostic & Research Centre Ltd has a market capitalization of 88.00 Cr, classifying it as a Micro Cap, with no available financial data for Net Sales and Net Profit for the latest four quarters. Shareholder's Funds are 20.73 Cr and Total Assets are 64.57 Cr as of March 2025.

As of 10th June, <BR><BR>Market Cap: Modern Diagnostic & Research Centre Ltd has a market capitalization of 88.00 Cr, categorizing it as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 20.73 Cr and Total Assets totaling 64.57 Cr.

Who are the peers of the Modern Diagnost.?

Peers of Modern Diagnost. include Star Imaging, Jeevan Scienti., Bilcare, Aspira Pathlab, Choksi Laborator, Royal Sense, Shree Pacetronix, Amkay Products, and Aakaar Medical. Management and growth risks vary, with Royal Sense showing excellent growth and Jeevan Scienti. having the highest 1-year return at 95.63%.

Peers: The peers of Modern Diagnost. are Star Imaging, Jeevan Scienti., Bilcare, Aspira Pathlab, Choksi Laborator, Royal Sense, Shree Pacetronix, Amkay Products, Aakaar Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at Star Imaging, while Good management risk is found at Royal Sense, Shree Pacetronix, Amkay Products, and Aakaar Medical. Below Average management risk is present at Jeevan Scienti., Bilcare, Aspira Pathlab, and Choksi Laborator. For Growth, Excellent growth is seen at Royal Sense, while Good growth is noted at Choksi Laborator, Shree Pacetronix, and Aakaar Medical. Below Average growth is reported at Star Imaging, Jeevan Scienti., Bilcare, Aspira Pathlab, and Amkay Products. Capital Structure ratings show Excellent at Star Imaging, Good at Royal Sense, Shree Pacetronix, Amkay Products, and Aakaar Medical, and Average at Jeevan Scienti. and Aspira Pathlab, while Below Average is noted for Bilcare and Choksi Laborator.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Jeevan Scienti. at 95.63%, while Bilcare has the lowest at -24.68%. Modern Diagnost.'s 1-year return is not available for comparison. Additionally, Royal Sense, Shree Pacetronix, and Bilcare have negative six-month returns.

When is the next results date for Modern Diagnostic & Research Centre Ltd?

The next results date for Modern Diagnostic & Research Centre Ltd is 29 May 2026.

The next results date for Modern Diagnostic & Research Centre Ltd is scheduled for 29 May 2026.